![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer
Publisher: Science Publishers
ISSN: 2049-9450
Source: Molecular and Clinical Oncology, Vol.4, Iss.1, 2016-01, pp. : 23-30
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)